APA's 2002 Annual Convention features speakers discussing topics that members want more information on. They include:
Harvard University political scientist Robert D. Putnam, PhD, on "Civic engagement and social capital: America after 9/11."
Joseph E. LeDoux, PhD, professor at the Center for Neural Science at New York University, and author of "The Emotional Brain: The Mysterious Underpinnings of Emotional Life," on "Synaptic self: how our brains become who we are."
University of Miami Medical School researcher Tiffany Field, PhD, on "The power of touch."
New Yorker magazine columnist and author of "The Tipping Point" Malcolm Gladwell, on "The quarterback problem."
Stanford University professor Claude Steele, PhD, on "Social identity threat in a diverse society."
Best-selling author Gail Sheehy on "Homeland's response to 9/11 terrorism."
Director of the University of California, San Francisco Research Institute Thomas J. Coates, PhD, on "AIDS: psychology's challenge."
Psychologist and Harvard business administration professor Teresa Amabile, PhD, on "Stalking creativity: from the laboratory to the workplace."
APA President and Stanford University professor Philip G. Zimbardo, PhD, on "Why and how normal people go mad."
Other don't-miss sessions feature:
Heart-health guru Dean Ornish, MD; Herbert Benson, MD, the Mind/Body Medical Institute associate professor of medicineat Harvard Medical School; and Psychology Today Founding Editor T George Harris on "Health, emotions and spirituality."
Steven Hassan, M.Ed. LMHC, NCC , Kerry Noble, PhD, Deborah Layton, PhD, and Stephen Morgan, PhD, on "Cults of hatred."
Dennis Embry, PhD, George Albee, PhD, Martin E.P. Seligman, PhD, and Larry James, PhD, on "New models of health-care delivery after Sept. 11."
Ariel Merari, Morgan Banks, Marc Sageman and Clark McCauley on "The psychology of terrorism."
And be sure to see our featured debates:
Albert Ellis, PhD, and Derald Wing Sue, PhD, on REBT and multiculturalism.
David Barlow, PhD, Diane Chambless, PhD, Larry Beutler, PhD, and Bruce Wampold, PhD, tackling empirically supported treatments.